Response to treatment with Interferon beta-1a in patients with relapsing-remitting multiple sclerosis
<p><strong>Background:</strong> multiple sclerosis modifying drugs are intended to reduce the frequency of relapses, delay the progression of disability, as well as the appearance of new lesions in the Central Nervous System.<br /><strong>Objective:</strong> to de...
Saved in:
| Main Authors: | Làzaro Aurelio Vàzquez Gòmez, Carlos Hidalgo Mesa, Yunier Broche Pèrez, Yanet Valdés Morales |
|---|---|
| Format: | Article |
| Language: | Spanish |
| Published: |
Centro Provincial de Información de Ciencias Médicas. Cienfuegos
2022-10-01
|
| Series: | Medisur |
| Subjects: | |
| Online Access: | http://medisur.sld.cu/index.php/medisur/article/view/5396 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evolución clínica de pacientes con esclerosis múltiple remitente- recurrente tratados con interferón beta-1a
by: Lazaro Aurelio Vazquez-Gomez, et al.
Published: (2022-09-01) -
Fear of Relapse Scale: Spanish version and psychometric characteristics in a sample of patients with Relapsing-Remitting multiple sclerosis
by: Y. Broche-Pérez, et al.
Published: (2024-11-01) -
Caracterización clínica de pacientes con esclerosis múltiple
by: Roberto Luis Lotti Mesa, et al.
Published: (2023-03-01) -
Survey on first-line therapeutic management of relapsing–remitting multiple sclerosis in clinical practice in Spain
by: M. Llaneza, et al.
Published: (2025-01-01) -
Epidemiological, clinical and imaging profile of Multiple Sclerosis
by: Làzaro Aurelio Vàzquez Gòmez, et al.
Published: (2021-12-01)